Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BriaCell Therapeutics Corp. - Common Shares (NQ: BCTX )

4.350 +0.520 (+13.58%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BriaCell Therapeutics Corp. - Common Shares

< Previous 1 2 3 Next >
Biotechs on the Brink: 2 Stocks With Huge Potential
BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out. 
Via MarketBeat
BioMedNewsBreaks — BriaCell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) Announces Pricing of $3.05M Public Offering
Via Investor Brand Network
Traders are paying attention to the gapping stocks in Tuesday's session.
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Discover the top movers in Tuesday's pre-market session.
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Why BriaCell Therapeutics (BCTX) Stock Is Down 40%
BriaCell Therapeutics shares are trading lower by 40% Thursday afternoon. The company announced the pricing of a $5.5 million public offering. 
Via Benzinga
BriaCell: An Emerging Immuno - Oncology Company
BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer. 
Via Talk Markets
Exposures Product Safety
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Get insights into the top gainers and losers of Monday's after-hours session.
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
BriaCell Stock Climbs After ‘Unprecedented’ Immunotherapy Response In Breast Cancer Patient, Retail Exudes Optimism
Bria-OTS is a next-generation, personalized advancement of BriaCell’s lead candidate, Bria-IMT, which is currently in a pivotal Phase 3 study for metastatic breast cancer. 
Via Stocktwits
Let's take a look at the stocks that are in motion in today's session.
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
New Treatments May Help Those With Advanced Breast Cancer Live Longer
Via StatePoint Media
Here are the top movers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
Via Benzinga
Exposures Fossil Fuels
Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge
Via Benzinga
Exposures Fossil Fuels
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor. 
Via Benzinga
Dow Tumbles 350 Points; US Inflation Rate Slows In August
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024
BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning! 
Via InvestorPlace
BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024
BriaCell Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
Get Rich Quick With These 3 Penny Stocks to Buy Now
Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick. 
Via InvestorPlace
Topics Economy
Exposures Economy
BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients... 
Via Benzinga
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food... 
Via FinancialNewsMedia
Exposures Product Safety
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment 
Via TheNewswire.com
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.